RVNC - Revance Therapeutics EPS misses by $0.24 misses on revenue May, 07 2020 04:14 PM Revance Therapeutics Inc. Revance Therapeutics (NASDAQ:RVNC): Q1 GAAP EPS of -$1.15 misses by $0.24.More news on: Revance Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...